If your medication is discontinued following attaining fat reduction, a risk of rebound body weight gain exists. This was demonstrated within an extension of your Stage 1 demo, where by participants, right after discontinuing weekly subcutaneous semaglutide two.Which means Introducing once-weekly tirzepatide vs prandial insulin lispro to insulin gl